DK1751181T3 - BINDINGSDELE, DER ER BASERET PÅ HAJ IgNAR-DOMÆNER - Google Patents
BINDINGSDELE, DER ER BASERET PÅ HAJ IgNAR-DOMÆNERInfo
- Publication number
- DK1751181T3 DK1751181T3 DK05744734.4T DK05744734T DK1751181T3 DK 1751181 T3 DK1751181 T3 DK 1751181T3 DK 05744734 T DK05744734 T DK 05744734T DK 1751181 T3 DK1751181 T3 DK 1751181T3
- Authority
- DK
- Denmark
- Prior art keywords
- haj
- parts based
- binding parts
- ignar domains
- ignar
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57584504P | 2004-06-02 | 2004-06-02 | |
| PCT/AU2005/000789 WO2005118629A1 (en) | 2004-06-02 | 2005-06-02 | BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1751181T3 true DK1751181T3 (da) | 2012-11-26 |
Family
ID=35462883
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05744734.4T DK1751181T3 (da) | 2004-06-02 | 2005-06-02 | BINDINGSDELE, DER ER BASERET PÅ HAJ IgNAR-DOMÆNER |
| DK10179638.1T DK2330121T3 (da) | 2004-06-02 | 2005-06-02 | Bindingsdele baseret på haj-IgNar-domæner |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10179638.1T DK2330121T3 (da) | 2004-06-02 | 2005-06-02 | Bindingsdele baseret på haj-IgNar-domæner |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7977071B2 (da) |
| EP (3) | EP1751181B1 (da) |
| JP (2) | JP2008511286A (da) |
| AU (3) | AU2005250055B2 (da) |
| CA (1) | CA2567655C (da) |
| DK (2) | DK1751181T3 (da) |
| WO (1) | WO2005118629A1 (da) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| JP2008507294A (ja) | 2004-07-26 | 2008-03-13 | ダウ グローバル テクノロジーズ インコーポレイティド | 菌株遺伝子操作による改善されたタンパク質発現のための方法 |
| EP2615172A1 (en) | 2007-04-27 | 2013-07-17 | Pfenex Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| JP5240870B2 (ja) | 2007-07-03 | 2013-07-17 | アブリンクス エン．ヴェー． | 改善した免疫グロブリン配列を提供する方法 |
| WO2009026638A1 (en) * | 2007-08-31 | 2009-03-05 | Melbourne Health | Marine-animal derived therapeutic and diagnostic agents for hepatitis b |
| CN102105786B (zh) | 2008-07-25 | 2014-10-29 | 赛乐思迪斯有限公司 | 诊断方法 |
| US20100136584A1 (en) * | 2008-09-22 | 2010-06-03 | Icb International, Inc. | Methods for using antibodies and analogs thereof |
| WO2010033913A1 (en) * | 2008-09-22 | 2010-03-25 | Icb International, Inc. | Antibodies, analogs and uses thereof |
| EP2344545A4 (en) * | 2008-10-06 | 2012-10-03 | Commw Scient Ind Res Org | CRYSTALLINE STRUCTURE OF BETA-AMYLOID PEPTIDE |
| CN102549012B (zh) | 2009-05-07 | 2015-07-01 | 诺维信生物制药丹麦公司 | 纯化白蛋白的方法 |
| US9290577B2 (en) | 2009-07-03 | 2016-03-22 | Avipep Pty Limited | Immuno-conjugates and methods for producing them |
| WO2011056056A2 (es) | 2009-11-04 | 2011-05-12 | Laboratorios Silanes, S.A. De C.V. | Dominios vhnar anti -citocinas |
| WO2011075773A1 (en) | 2009-12-23 | 2011-06-30 | Cellestis Limited | An assay for measuring cell-mediated immunoresponsiveness |
| SG181814A1 (en) | 2009-12-23 | 2012-07-30 | Avipep Pty Ltd | Immuno-conjugates and methods for producing them 2 |
| US9624294B2 (en) | 2011-03-14 | 2017-04-18 | Cellmid Limited | Antibody recognizing N-domain of midkine |
| CN109298170A (zh) | 2011-04-29 | 2019-02-01 | 塞尔雷斯蒂斯有限公司 | 细胞介导的免疫应答力试验 |
| CA2838246C (en) | 2011-06-13 | 2018-07-10 | Csl Limited | Antibodies against g-csfr and uses thereof |
| ES2673697T5 (es) | 2011-06-29 | 2022-09-14 | Cellestis Ltd | Un ensayo de la respuesta inmunitaria mediada por células con sensibilidad incrementada |
| AU2012327878A1 (en) | 2011-10-28 | 2014-05-29 | Patrys Limited | PAT-LM1 epitopes and methods for using same |
| CA2863224A1 (en) | 2012-01-09 | 2013-07-18 | The Scripps Research Institute | Ultralong complementarity determining regions and uses thereof |
| US10112987B2 (en) * | 2012-01-09 | 2018-10-30 | Icb International, Inc. | Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide |
| US10112988B2 (en) * | 2012-01-09 | 2018-10-30 | Icb International, Inc. | Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide |
| MX347154B (es) | 2012-02-24 | 2017-02-21 | Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese) | Prueba de diagnóstico para enfermedades infecciosas en ganado bovino. |
| WO2013167883A1 (en) | 2012-05-07 | 2013-11-14 | The University Court Of The University Of Aberdeen | Single domain binding molecule |
| PL3745128T3 (pl) | 2012-12-28 | 2025-09-22 | Qiagen Sciences Llc | Test odpowiedzi immunologicznej pośredniczony przez komórki |
| WO2014110368A1 (en) | 2013-01-11 | 2014-07-17 | The California Institute For Biomedical Research | Bovine fusion antibodies |
| EP2762496A1 (en) | 2013-02-05 | 2014-08-06 | EngMab AG | Method for the selection of antibodies against BCMA |
| PL2953972T3 (pl) | 2013-02-05 | 2021-03-08 | Engmab Sàrl | Metoda wyboru przeciwciał przeciwko bcma |
| EP2953971B1 (en) | 2013-02-07 | 2023-03-01 | CSL Limited | Il-11r binding proteins and uses thereof |
| EP2789630A1 (en) | 2013-04-09 | 2014-10-15 | EngMab AG | Bispecific antibodies against CD3e and ROR1 |
| KR102320189B1 (ko) | 2013-04-23 | 2021-11-03 | 엘라스모겐 리미티드 | 특이적 결합 분자의 합성 라이브러리 |
| DK3074038T3 (da) | 2013-11-28 | 2019-03-11 | Csl Ltd | Fremgangsmåde til behandling af diabetisk nephropati |
| JP6553618B2 (ja) | 2013-12-18 | 2019-07-31 | シーエスエル リミティド | 創傷を治療する方法 |
| US10435474B2 (en) | 2013-12-24 | 2019-10-08 | Ossianix, Inc. | Baff selective binding compounds and related methods |
| MX2016013613A (es) | 2014-04-17 | 2017-02-28 | Teraclón Idf S L | Anticuerpos monoclonales recombinantes vnar neutralizantes del factor de crecimiento del endotelio vascular vegf. |
| JP6454981B2 (ja) * | 2014-04-24 | 2019-01-23 | 住友電気工業株式会社 | 半導体積層体および受光素子 |
| JP6355020B2 (ja) * | 2014-05-14 | 2018-07-11 | パナソニックＩｐマネジメント株式会社 | 目元用美容装置 |
| WO2015200883A2 (en) | 2014-06-26 | 2015-12-30 | Ossianix, Inc. | Semi-synthetic nurse shark vnar libraries for making and using selective binding compounds |
| EP3204415B1 (en) | 2014-10-09 | 2020-06-17 | EngMab Sàrl | Bispecific antibodies against cd3epsilon and ror1 |
| WO2016061632A1 (en) | 2014-10-23 | 2016-04-28 | La Trobe University | Fn14-binding proteins and uses thereof |
| EP3511711A1 (en) | 2014-10-23 | 2019-07-17 | Qiagen Sciences, LLC | Peptide composition and uses thereof |
| CA2967830A1 (en) | 2014-11-14 | 2016-05-19 | Ossianix, Inc. | Tfr selective binding compounds and related methods |
| AU2015367224B2 (en) | 2014-12-19 | 2020-12-10 | Monash University | IL-21 antibodies |
| WO2016109872A1 (en) | 2015-01-09 | 2016-07-14 | Adalta Pty Ltd | Cxcr4 binding molecules |
| WO2016198470A2 (en) | 2015-06-08 | 2016-12-15 | Lophius Biosciences Gmbh | Composition for determination of cell-mediated immune responsiveness |
| PT3331910T (pt) | 2015-08-03 | 2020-03-24 | Engmab Sarl | Anticorpos monoclonais contra o antigénio de maturação de células b (bcma) humano |
| KR20180043841A (ko) | 2015-09-11 | 2018-04-30 | 카리나 바이오테크 피티와이 엘티디 | 키메라 항원 수용체 및 이의 용도 |
| US10273196B2 (en) | 2015-09-25 | 2019-04-30 | Exxonmobil Chemical Patents Inc. | Hydrocarbon dehydrocyclization |
| SG10201912051TA (en) | 2015-11-27 | 2020-02-27 | Csl Ltd | Cd131 binding proteins and uses thereof |
| WO2017191108A1 (en) | 2016-05-02 | 2017-11-09 | Ablynx Nv | Treatment of rsv infection |
| US20190248920A1 (en) | 2016-09-23 | 2019-08-15 | Csl Limited | Coagulation factor binding proteins and uses thereof |
| US11124577B2 (en) | 2016-11-02 | 2021-09-21 | Engmab Sàrl | Bispecific antibody against BCMA and CD3 and an immunological drug for combined use in treating multiple myeloma |
| WO2018084712A1 (en) | 2016-11-07 | 2018-05-11 | Crossbeta Biosciences B.V. | Novel amyloid beta oligomer specific binding molecule |
| MX2019012566A (es) | 2017-04-21 | 2019-12-02 | Centro De Investig Cientifica Y De Educacion Superior De Ensenada Baja California | Vnar con actividad anti-angiogenica en tumores solidos de animales de compa?ia. |
| EP3652209A2 (en) | 2017-07-11 | 2020-05-20 | Compass Therapeutics LLC | Agonist antibodies that bind human cd137 and uses thereof |
| JP7733443B2 (ja) | 2017-09-11 | 2025-09-03 | モナシュ ユニバーシティー | ヒトトロンビン受容体ｐａｒ４に対する結合タンパク質 |
| WO2019063726A1 (en) | 2017-09-27 | 2019-04-04 | Elasmogen Ltd | SPECIFIC BINDING MOLECULES |
| US20200354452A1 (en) | 2017-09-29 | 2020-11-12 | City Of Hope | Cars and bispecific antibodies for treatment of mantle cell lymphoma |
| WO2019089753A2 (en) | 2017-10-31 | 2019-05-09 | Compass Therapeutics Llc | Cd137 antibodies and pd-1 antagonists and uses thereof |
| US11180544B2 (en) * | 2017-11-07 | 2021-11-23 | City University Of Hong Kong | Method of producing antibody fragment |
| US11851497B2 (en) | 2017-11-20 | 2023-12-26 | Compass Therapeutics Llc | CD137 antibodies and tumor antigen-targeting antibodies and uses thereof |
| PL3717011T3 (pl) | 2017-11-29 | 2023-03-27 | Csl Limited | Sposób leczenia lub zapobiegania uszkodzeniu niedokrwienno- reperfuzyjnemu |
| WO2019178645A1 (en) | 2018-03-23 | 2019-09-26 | Csl Limited | Method of treating asthma |
| WO2020041758A1 (en) | 2018-08-24 | 2020-02-27 | City Of Hope | Masked cytokine conjugates |
| WO2020056327A1 (en) | 2018-09-14 | 2020-03-19 | Ossianix, Inc. | Tfr-specific binding moieties and transcytosis method to select vnars that cross cellular barriers |
| CA3118692A1 (en) | 2018-11-06 | 2020-05-14 | Alsatech, Inc. | Cell-based gene therapy for neurodegenerative diseases |
| MX2021005594A (es) | 2018-11-13 | 2021-10-22 | Compass Therapeutics Llc | Constructos multiespecificos de union contra moleculas de puntos de control y usos de los mismos. |
| US20230303654A1 (en) | 2020-08-11 | 2023-09-28 | City Of Hope | Compositions and uses of sars-cov-2 targeted chimeric antigen receptor modified nk cells |
| GB202020152D0 (en) | 2020-12-18 | 2021-02-03 | Elasmogen Ltd | Fast-track humanisation of specific binding molecules |
| US20250297020A1 (en) * | 2021-11-23 | 2025-09-25 | Adalta Limited | Rank-l binding molecules |
| PE20251082A1 (es) | 2022-07-08 | 2025-04-10 | Novo Nordisk As | Compuestos de isvd altamente potentes capaces de sustituir al fviii(a) |
| AR129879A1 (es) | 2022-07-08 | 2024-10-09 | Novo Nordisk As | Compuestos de isvd altamente potentes capaces de sustituir al fviii(a) |
| CN116284423B (zh) * | 2022-12-29 | 2023-10-03 | 江苏百英生物科技有限公司 | 一种靶向条纹斑竹鲨IgNAR-CH1多克隆抗体、其制备方法及其应用 |
| AU2024245676A1 (en) | 2023-03-30 | 2025-10-09 | 272BIO Limited | Gnrh-binding polypeptides and uses thereof |
| WO2025007195A1 (en) | 2023-07-05 | 2025-01-09 | CSL Innovation Pty Ltd | Methods of treating or preventing a complication of sickle cell disease |
| CN118702816B (zh) * | 2024-06-03 | 2025-03-28 | 内蒙古正德缘生物科技有限责任公司 | 一种nk细胞及其在抗肿瘤治疗中的应用 |
| CN119529102B (zh) * | 2025-01-22 | 2025-06-17 | 青岛科技大学 | 一种靶向胰脂肪酶的鲨鱼纳米抗体制备方法及其应用 |
| CN120173114B (zh) * | 2025-03-24 | 2025-09-26 | 广州泽朗生物医药科技有限公司 | Cart细胞及其在制备抗癌症药物中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| WO1990005144A1 (en) | 1988-11-11 | 1990-05-17 | Medical Research Council | Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| GB8927230D0 (en) | 1989-12-01 | 1990-01-31 | Unilever Plc | Reagents |
| US5955363A (en) | 1990-01-03 | 1999-09-21 | Promega Corporation | Vector for in vitro mutagenesis and use thereof |
| DE69427974T2 (de) | 1993-04-29 | 2001-12-06 | Unilever N.V., Rotterdam | Herstellung von antikörpern oder funktionstüchtig gemachten teilen davon, abgeleitet von schweren ketten von immunglobulinen von camelidae |
| EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| EP1295952A3 (en) | 1996-01-23 | 2003-07-09 | The Board of Trustees of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
| AU747637B2 (en) * | 1998-03-06 | 2002-05-16 | Arana Therapeutics (Vic) Pty Ltd | V-like domain binding molecules |
| AUPP221098A0 (en) * | 1998-03-06 | 1998-04-02 | Diatech Pty Ltd | V-like domain binding molecules |
| AU1325102A (en) * | 2000-10-16 | 2002-04-29 | Phylos Inc | Protein scaffolds for antibody mimics and other binding proteins |
| CA2457636C (en) * | 2001-08-10 | 2012-01-03 | Aberdeen University | Antigen binding domains |
| JP4317940B2 (ja) * | 2001-08-31 | 2009-08-19 | イミュノコア・リミテッド | 物質 |
| AU2002351896A1 (en) * | 2001-12-11 | 2003-06-23 | Ablynx N.V. | Method for displaying loops from immunoglobulin domains in different contexts |
| US20040266993A1 (en) * | 2003-06-30 | 2004-12-30 | Evans Glen A. | Non-immunoglobulin binding polypeptides |
-
2005
- 2005-06-02 CA CA2567655A patent/CA2567655C/en not_active Expired - Lifetime
- 2005-06-02 US US11/628,475 patent/US7977071B2/en not_active Expired - Lifetime
- 2005-06-02 EP EP05744734A patent/EP1751181B1/en not_active Expired - Lifetime
- 2005-06-02 EP EP10179611A patent/EP2330120A3/en not_active Withdrawn
- 2005-06-02 DK DK05744734.4T patent/DK1751181T3/da active
- 2005-06-02 JP JP2007513617A patent/JP2008511286A/ja active Pending
- 2005-06-02 AU AU2005250055A patent/AU2005250055B2/en not_active Expired
- 2005-06-02 DK DK10179638.1T patent/DK2330121T3/da active
- 2005-06-02 WO PCT/AU2005/000789 patent/WO2005118629A1/en not_active Ceased
- 2005-06-02 EP EP10179638.1A patent/EP2330121B1/en not_active Expired - Lifetime
-
2008
- 2008-09-29 AU AU2008229687A patent/AU2008229687B2/en not_active Expired
-
2009
- 2009-04-28 AU AU2009201692A patent/AU2009201692B2/en not_active Expired
-
2011
- 2011-06-09 US US13/157,205 patent/US20120003214A1/en not_active Abandoned
- 2011-06-10 JP JP2011130413A patent/JP5631812B2/ja not_active Expired - Fee Related
-
2016
- 2016-02-16 US US15/044,731 patent/US20160237169A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2330121A3 (en) | 2011-11-16 |
| EP1751181A4 (en) | 2008-03-12 |
| EP1751181B1 (en) | 2012-08-15 |
| CA2567655A1 (en) | 2005-12-15 |
| EP1751181A1 (en) | 2007-02-14 |
| CA2567655C (en) | 2015-06-30 |
| JP2011244822A (ja) | 2011-12-08 |
| EP2330121A2 (en) | 2011-06-08 |
| AU2009201692B2 (en) | 2012-08-30 |
| US20090148438A1 (en) | 2009-06-11 |
| EP2330121B1 (en) | 2014-09-03 |
| AU2008229687B2 (en) | 2009-01-29 |
| JP5631812B2 (ja) | 2014-11-26 |
| EP2330120A3 (en) | 2011-11-16 |
| US20160237169A1 (en) | 2016-08-18 |
| AU2005250055B2 (en) | 2008-09-11 |
| AU2009201692A1 (en) | 2009-05-21 |
| EP2330120A2 (en) | 2011-06-08 |
| WO2005118629A1 (en) | 2005-12-15 |
| DK2330121T3 (da) | 2014-12-15 |
| US20120003214A1 (en) | 2012-01-05 |
| US7977071B2 (en) | 2011-07-12 |
| JP2008511286A (ja) | 2008-04-17 |
| AU2005250055A1 (en) | 2005-12-15 |
| AU2008229687A1 (en) | 2008-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1751181T3 (da) | BINDINGSDELE, DER ER BASERET PÅ HAJ IgNAR-DOMÆNER | |
| CY2020009I2 (el) | Δεσμευτικοι παραγοντες σκληροστινης | |
| DK1776383T3 (da) | Bindingsmolekyler | |
| LT3339445T (lt) | Baltymai, suryšantys interleukiną 13 | |
| NO20053161D0 (no) | Mikrobedrepende sammensetning. | |
| DE602005022897D1 (de) | Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen | |
| DK1881377T3 (da) | Skydelukker og tonertilførselsapparat, der omfatter skydelukkeren | |
| DE602005007121D1 (de) | Phasenaustauschtinten | |
| DE602006019257D1 (de) | Bindevorrichtung mit ringen | |
| NL1033745A1 (nl) | Sleepboot. | |
| DE602005022760D1 (de) | Azo-verbindungen | |
| EP1829706A4 (en) | STORAGE DEVICE | |
| ES1058958Y (es) | Mastil perfeccionado. | |
| FR2864891B1 (fr) | Compensateur dorsal | |
| ES1056663Y (es) | Abrazadera. | |
| AT504183A3 (de) | Skibindungssystem | |
| FI20050547A0 (fi) | Side | |
| FI20041350A0 (fi) | Sidontalaite | |
| ES1056835Y (es) | Pantalon perfeccionado. | |
| FI20050009A0 (fi) | Sidontalaite | |
| FI20050927A0 (fi) | Sidontalaite | |
| FI20050718A0 (fi) | Sidontalaite | |
| FI20050349A0 (fi) | Sidontalaite | |
| ES1058527Y (es) | Biberon perfeccionado. | |
| ES1057402Y (es) | Celosia perfeccionada. |